Resources » Laboratory sciences track | WFH World Congress 2022

Year: 2022

Language: English

Author(s): World Federation of Hemophilia

Format: Congress recordings

Laboratory sciences track | WFH World Congress 2022


In these sessions from the WFH 2022 World Congress, listen to Pierre Toulon, Silmara Montalvao, Steve Kitchen, Sukesh Nair,Yesim Dargaud, Marie-Christine Alessi, Annette Bowyer, Veronica Flood, Emmanuel Favaloro and Connie Miller address current topics in laboratory sciences.

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

In this session from the WFH 2022 World Congress, Pierre Toulon (France), Silmara Montalvao (Brazil), Steve Kitchen (United Kingdom) and Sukesh Nair (India), discuss using the External Quality Assessment as a tool to improve lab diagnosis in a country; the evaluation of Factor VIII/IX inhibitor testing practices: results from the UK NEQAS Blood Coagulation and WFH IEQAS programs; and quality control in the limited resource countries.

In this workshop from the WFH 2022 World Congress, Pierre Toulon (France), Steve Kitchen (United Kingdom), Yesim Dargaud (France), Sukesh Nair (India) and Marie-Christine Alessi (France), discuss pre-analytic issues for coagulation testing, how to investigate isolated unexplained prolonged APTT; the usefulness of global assay for monitoring hemophilia treatments; screening for an inhibitor in limited resource countries, and laboratory diagnosis of hereditary platelet function disorders.

In this session from the WFH 2022 World Congress, Annette Bowyer (United Kingdom), Veronica Flood (United States), Emmanuel Favaloro (Australia) and Connie H. Miller (United States), give an update in the laboratory diagnosis of von Willebrand disease (VWD), including issues in von Willebrand factor (VWF) diagnosis, and monitoring of VWF inhibitors.